XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations (unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Collaboration revenue $ 4,148 $ 0 $ 4,148 $ 0
Operating expenses:        
Research and development 13,887 7,265 24,832 12,082
General and administrative 5,233 3,691 9,654 6,326
Total operating expenses 19,120 10,956 34,486 18,408
Operating loss (14,972) (10,956) (30,338) (18,408)
Other income:        
Other income (expense), net 281 (16) 265 (32)
Interest income 97 51 136 84
Total other income 378 35 401 52
Net loss (14,594) (10,921) (29,937) (18,356)
Accretion of redeemable convertible preferred stock to redemption value 0 (56,926) 0 (151,942)
Net loss attributable to common stockholders (14,594) (67,847) (29,937) (170,298)
Net loss attributable to common stockholders $ (14,594) $ (67,847) $ (29,937) $ (170,298)
Net loss per share attributable to common stockholders, basic and diluted        
Net (loss) per share attributable to common stockholders, basic (usd per share) $ (0.53) $ (3.82) $ (1.09) $ (17.86)
Net (loss) per share attributable to common stockholders, diluted (usd per share) $ (0.53) $ (3.82) $ (1.09) $ (17.86)
Weighted-average common shares outstanding, basic and diluted        
Weighted average common shares outstanding, basic (shares) 27,517 17,750 27,455 9,535
Weighted average common shares outstanding, diluted (shares) 27,517 17,750 27,455 9,535